FASLG and fetal growth restriction: New pathogenic mechanisms of aPL-mediated pregnancy loss have been investigated in recent years, and this may be helpful in finding specific targets for future treatment proposals for refractory cases.6 The main question is whether the treatment can prevent the development of PE and intrauterine growth restriction in aPL-positive patients.